Loading insider details...
Beta
Latest Form 4 (Jun 16, 2025): Grant/Award of 5,398 EXAS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 16, 2025 | EXACT SCIENCES CORP (EXAS) | Grant/Award | 5,398 | n/a |
| Jun 17, 2024 | EXACT SCIENCES CORP (EXAS) | Grant/Award | 5,444 | n/a |
| Mar 5, 2024 | EXACT SCIENCES CORP (EXAS) | Sale | 5,000 | $287.5K |
| Nov 22, 2023 | Renalytix plc (RNLX) | Grant/Award | 95,000 | n/a |
| Jun 12, 2023 | EXACT SCIENCES CORP (EXAS) | Grant/Award | 4,678 | n/a |
| Jun 13, 2022 | EXACT SCIENCES CORP (EXAS) | Grant/Award | 5,606 | n/a |
| Jul 2, 2021 | EXACT SCIENCES CORP (EXAS) | Grant/Award | 2,675 | n/a |
| Aug 4, 2020 | EXACT SCIENCES CORP (EXAS) | Exercise/Conversion | 4,608 | $46.9K |
| Jul 24, 2020 | EXACT SCIENCES CORP (EXAS) | Grant/Award | 2,558 | n/a |